Cite
HARVARD Citation
Garey, K. et al. (2022). Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial . Clinical infectious diseases. pp. 1164-1170. [Online].